PNI’s mission is to accelerate the development of transformative medicines. PNI’s proprietary technologies solve critical challenges in discovering, developing and manufacturing nanotechnology delivered drugs. PNI is working with leading pharmaceutical, biotechnology, and academic groups to develop novel nanomedicines and bring these cutting edge therapeutics to patients. Precision NanoSystems Inc. In neuroscience, translating computational genomics insights into practice is hindered by difficulties in transfecting neurons. To tackle this, the Hornstein Lab at the Weizmann Institute of Science have published a protocol describing functional genomics screens with primary neurons in 384-well format. They’ve employed Precision NanoSystems’ Neuro9™ transfection technology because it shows no observable toxicity and can be pipetted directly to cell culture making it ideal for automated fluid handling. PNI’s mission is to accelerate the development of transformative medicines. PNI’s proprietary technologies solve critical challenges in discovering, developing and manufacturing nanotechnology delivered drugs. PNI is working with leading pharmaceutical, biotechnology, and academic groups to develop novel nanomedicines and bring these cutting edge therapeutics to patients. Precision NanoSystems Inc. In neuroscience, translating computational genomics insights into practice is hindered by difficulties in transfecting neurons. To tackle this, the Hornstein Lab at the Weizmann Institute of Science have published a protocol describing functional genomics screens with primary neurons in 384-well format. They’ve employed Precision NanoSystems’ Neuro9™ transfection technology because it shows no observable toxicity and can be pipetted directly to cell culture making it ideal for automated fluid handling.

Vaccines & Vaccination, veterinary sciences